Imatinib is successfully used for the treatment of several malignancies, such as Philadelphia chromosome-positive chronic myelogenous leukaemia (CML) [9], acute lymphoblastic leukaemia (ALL) [10] and KIT-positive gastrointestinal stromal tumors (GISTs) [11]. This evidence concerns the gene KIT and acute lymphoblastic leukemia.